Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional testing.

R T Moxley1

  • 1Neuromuscular Division, University of Rochester Medical Center, New York.

Muscle & Nerve
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Functional testing monitors neuromuscular disorder progression and treatment efficacy. Despite limitations, its use of daily activities offers reliable, sensitive, and patient-preferred insights into disease course.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival patterns and cancer determinants in families with myotonic dystrophy type 1.

European journal of neurology·2018
Same author

Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy.

European journal of neurology·2017
Same author

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Neurology·2010
Same author

Distal myasthenia gravis with a decrement, an increment, and denervation.

Journal of clinical neuromuscular disease·2008
Same author

Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1.

Muscle & nerve·2005
Same author

Practice parameter: corticosteroid treatment of Duchenne dystrophy [RETIRED]: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Neurology·2005
Same journal

Fat-Fraction Quantification Using Three-Point Dixon Technique in Duchenne Muscular Dystrophy and Its Correlation With Clinical Progression and Genotypic Characteristics: A Single Centre One-Year Prospective Study.

Muscle & nerve·2026
Same journal

Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.

Muscle & nerve·2026
Same journal

Electrical Modalities in the Rehabilitation of Peripheral Nerve Injuries: State of the Literature and Current Clinical Applications.

Muscle & nerve·2026
Same journal

Reply to "Sural/Radial Amplitude Ratio in Non-Length-Dependent Neuropathy (NLDN): A Call for More Standardized Methodology and Further Evaluation of Distal NLDN".

Muscle & nerve·2026
Same journal

Late-Onset Myasthenia Gravis: An Increasingly Frequent Clinical Entity With Distinctive Challenges.

Muscle & nerve·2026
Same journal

Clinical Characteristics and Treatment Management of Seronegative Myasthenia Gravis: A Systematic Review of the Literature.

Muscle & nerve·2026
See all related articles

Area of Science:

  • Neurology
  • Clinical Trials
  • Rehabilitation Medicine

Background:

  • Functional testing is crucial for monitoring neuromuscular disorders and evaluating therapeutic interventions.
  • Traditional assessments like Manual Muscle Testing (MMT) and quantitative myometry can be insensitive or difficult to perform in later disease stages for conditions like DMD, ALS, and SMA.

Purpose of the Study:

  • To highlight the utility of functional testing in assessing neuromuscular disease progression and treatment efficacy.
  • To address the limitations of current functional testing methods and propose solutions for optimal application.

Main Methods:

  • Reviewing the principles and applications of functional testing in neuromuscular disease research.
  • Comparing functional testing with traditional strength measurements (MMT, myometry) across different disease stages.

Related Experiment Videos

  • Discussing the challenges in selecting appropriate functional tests and applying statistical analyses.

    • Main Results:

    • Functional testing, using daily activities, offers a sensitive and reliable method for tracking disease progression.
    • Patients often perceive functional improvements more readily than strength gains.
    • Functional tests are adaptable to various clinical settings with minimal cost and high standardization.

    Conclusions:

    • The advantages of functional testing, including patient relevance and ease of implementation, outweigh its limitations.
    • Identifying disease-specific functional tests is key for accurate natural history assessment and clinical trial design.
    • Functional testing aids clinicians in predicting disease trajectory and informing patient care.